Transcript – Doorstop – Canberra

E&OE… Topics: PBS expanded listing of Spinraza for pre-symptomatic children and infants with spinal muscular atrophy; Genetic screenings for SMA; Vaping; COVID-19 vaccine rollout strategy; Bringing overseas Australians home; International borders; Masks in Victoria. GREG HUNT: Seona and Hugo are parents of Chloe and Matilda, or Tilly. Tilly is a beautiful young girl, four years…

Life-saving SMA medicine to be made available to Australian babies

Access to a life-saving and life-changing medicine will soon be expanded for Australian children and infants with Spinal Muscular Atrophy (SMA), thanks to a breakthrough medicines listing on the Pharmaceutical Benefits Scheme (PBS). From 1 December, subsidised access to the life-changing medicine Spinraza® (nusinersen) will be expanded to include children and infants genetically diagnosed with…

New $4.57 million clinical training facility expands healthcare access in Bega

A new clinical training facility at the Bega Hospital will expand healthcare access for residents across the region, following its official opening today. The training facility will support medical, nursing, midwifery and allied health students to learn directly from health professionals and pursue their careers in Bega. Minister for Health, Greg Hunt, said the new…

Frankston to Baxter rail upgrade business case released

The electrification and duplication of the Frankston Line to Baxter could directly benefit residents across the entire Mornington Peninsula, according to the federally funded business case. The Commonwealth has committed $228 million to the project, including $3 million for the completion of the preliminary business case by the Victorian Government. Today a summary of the…

Australia well prepared for COVID-19 vaccine rollout

Australia is well placed for the rollout of a COVID-19 vaccine, once clinical trials and the regulator has confirmed safety and effectiveness. Under the Morrison Government’s COVID-19 Vaccine and Treatment Strategy, Australia has secured 134.8 million doses through advance purchasing agreements with four suppliers: AstraZeneca/Oxford, University of Queensland/CSL, Novavax and Pfizer/BioNTech. In addition, Australia has…